These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 7522176

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. PGD2 and its mimetic ZK 110.841 are potent inhibitors of receptor-mediated activation of human neutrophils.
    Ney P, Schrör K.
    Eicosanoids; 1991; 4(1):21-8. PubMed ID: 1647806
    [Abstract] [Full Text] [Related]

  • 3. Pro-inflammatory and anti-inflammatory effects of the stable prostaglandin D2 analogue, ZK 118.182.
    Pons F, Williams TJ, Kirk SA, McDonald F, Rossi AG.
    Eur J Pharmacol; 1994 Aug 22; 261(3):237-47. PubMed ID: 7813544
    [Abstract] [Full Text] [Related]

  • 4. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils.
    Bleasdale JE, Thakur NR, Gremban RS, Bundy GL, Fitzpatrick FA, Smith RJ, Bunting S.
    J Pharmacol Exp Ther; 1990 Nov 22; 255(2):756-68. PubMed ID: 2147038
    [Abstract] [Full Text] [Related]

  • 5. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
    Merritt JE, Hallam TJ, Brown AM, Boyfield I, Cooper DG, Hickey DM, Jaxa-Chamiec AA, Kaumann AJ, Keen M, Kelly E.
    Br J Pharmacol; 1991 Jan 22; 102(1):251-9. PubMed ID: 1710526
    [Abstract] [Full Text] [Related]

  • 6. Stimulation of prostaglandin D2 receptors on human platelets by analogs of prostacyclin.
    Alvarez R, Eglen RM, Chang LF, Bruno JJ, Artis DR, Kluge AF, Whiting RL.
    Prostaglandins; 1991 Aug 22; 42(2):105-19. PubMed ID: 1775633
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Stable 9 beta- or 11 alpha-halogen-15-cyclohexyl-prostaglandins with high affinity to the PGD2-receptor.
    Thierauch KH, Stürzebecher CS, Schillinger E, Rehwinkel H, Radüchel B, Skuballa W, Vorbrüggen H.
    Prostaglandins; 1988 Jun 22; 35(6):855-68. PubMed ID: 2847246
    [Abstract] [Full Text] [Related]

  • 9. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.
    Fisch A, Michael-Hepp J, Meyer J, Darius H.
    Eur J Pharmacol; 1995 May 26; 289(3):455-61. PubMed ID: 7556414
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cytotoxic enzyme release and oxygen centered radical formation in human neutrophils are selectively inhibited by E-type prostaglandins but not by PGI2.
    Hecker G, Ney P, Schrör K.
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Apr 26; 341(4):308-15. PubMed ID: 2159112
    [Abstract] [Full Text] [Related]

  • 12. Differential inhibition of human neutrophil activation by cyclosporins A, D, and H. Cyclosporin H is a potent and effective inhibitor of formyl peptide-induced superoxide formation.
    Wenzel-Seifert K, Grünbaum L, Seifert R.
    J Immunol; 1991 Sep 15; 147(6):1940-6. PubMed ID: 1653806
    [Abstract] [Full Text] [Related]

  • 13. Receptor-specific threshold effects of cyclic AMP are involved in the regulation of enzyme release and superoxide production from human neutrophils.
    Lad PM, Goldberg BJ, Smiley PA, Olson CV.
    Biochim Biophys Acta; 1985 Aug 30; 846(2):286-95. PubMed ID: 2411298
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of platelet function by polymorphonuclear leukocytes.
    Zatta A, Prosdocimi M, Bertelé V, Bazzoni G, Del Maschio A.
    J Lab Clin Med; 1990 Nov 30; 116(5):651-60. PubMed ID: 2146349
    [Abstract] [Full Text] [Related]

  • 15. Investigation of the cellular mechanism of inhibition of formyl-methionyl-leucyl-phenylalanine-induced superoxide anion generation in rat neutrophils by 2-benzyloxybenzaldehyde.
    Wang JP, Chang LC, Lin YL, Hsu MF, Chang CY, Huang LJ, Kuo SC.
    Biochem Pharmacol; 2003 Apr 01; 65(7):1043-51. PubMed ID: 12663040
    [Abstract] [Full Text] [Related]

  • 16. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K, Halushka PV, Yan YT, Wong PY.
    J Pharmacol Exp Ther; 1994 Sep 01; 270(3):1192-6. PubMed ID: 7932171
    [Abstract] [Full Text] [Related]

  • 17. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
    Seiler S, Brassard CL, Arnold AJ, Meanwell NA, Fleming JS, Keely SL.
    J Pharmacol Exp Ther; 1990 Dec 01; 255(3):1021-6. PubMed ID: 2175792
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.